rs4619875

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

arfaptin-1 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.34
p 5.0e-160
N 10,708
Large GWAS
European
Allele T
OR 0.15
p 3.0e-123
N 47,745
Large GWAS
European
Sun BB et al. Genomic atlas of the human plasma proteome. Nature 558(7708):73-79 (2018)
Allele T
OR 0.24
p 7.0e-22
N 3,301
Large GWAS
European

Red cell distribution width

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele T
OR 0.03
p 1.0e-38
N 408,112
Large GWAS
European
Allele T
OR
p 3.0e-34
N 563,352
Large GWAS
multi-ancestry
Allele T
OR 0.02
p 1.0e-37
N 394,642
Large GWAS
European
Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele T
OR 0.03
p 4.0e-23
N 380,796
Major Consortium StudyLarge GWAS
European

platelet volume

Allele T
OR 0.02
p 8.0e-20
N 394,642
Large GWAS
European
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele T
OR 0.02
p 5.0e-15
N 408,112
Large GWAS
European

matrix metalloproteinase-9 measurement

Allele T
OR 0.05
p 2.0e-17
N 47,745
Large GWAS
European

mean corpuscular hemoglobin concentration

Allele C
OR
p 4.0e-11
N 642,173
Large GWAS
multi-ancestry
Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele C
OR 0.02
p 4.0e-14
N 583,935
Major Consortium StudyLarge GWAS
multi-ancestry

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…